Waystar (WAY) said it will acquire health AI software company, Iodine Software, for a total enterprise value of $1.25B. The ...

Waystar plans to acquire AI-driven revenue cycle management company Iodine Software, its first acquisition since going public ...

The acquisition will enable Waystar to automate tasks such as utilisation management and clinical documentation integrity.

Healthcare software firm Waystar said on Wednesday it would buy privately held Iodine Software in a deal worth over $1.25 billion, including debt, to expand its use of artificial intelligence in ...

Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced a definitive agreement to acquire ...

Waystar has signed a definitive agreement to acquire AI-powered revenue cycle management company Iodine Software. The proposed $1.25 billion deal will be funded with a 50/50 mix of cash and stock ...

Louisville's newest public company raises nearly $1 billion © 2025 American City Business Journals. All rights reserved. Use ...

Waystar Holding Corp. shows revenue growth and strategic expansion with the Iodine acquisition. Click for why high valuations and muted growth may temper WAY's appeal.

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

Waystar to acquire Iodine Software for $1.25 billion to enhance AI tools; deal expected to be accretive to growth and margins by 2027.

Waystar expects full-year earnings in the range of $1.36 to $1.40 per share, with revenue in the range of $1.03 billion to $1.04 billion. This story was generated by Automated Insights ( ...

Waystar has agreed to acquire Iodine Software, an Austin-based provider of AI-powered clinical intelligence, for $1.25 billion. The sellers include majority shareholder Advent International and Iodine ...